Two Drugs With FDA Warnings May Benefit Some Heart Failure Patients

Armen Hareyan's picture

DALLAS, Feb. 8 - Two drugs that the U.S. Food and Drug Administration warns against using in many heart failure patients may benefit some diabetics with heart failure, according to an observational study in today's Circulation: Journal of the American Heart Association.

"Our study found that patients with heart failure and diabetes who were prescribed one or both of two types of diabetes drugs -- metformin and thiazolidinediones -- had lower death rates than those who did not receive these drugs," said lead author Frederick A. Masoudi, M.D., M.S.P.H., assistant professor of medicine at Denver Health Medical Center and the University of Colorado Health Sciences Center.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.